TPG Biotech is a private equity general partner firm headquartered in San Francisco, CA, United States.
Genoa Pharmaceuticals, a Seattle-based biopharmaceutical company, raised $62m in Series A from F-Prime Capital Partners and others.
Progyny, a NY-based fertility benefits company, raised $10m in Series B from Kleiner Perkins Caufield and Byers, TPG Biotech and others.
Biopharmaceutical company Fusion Pharmaceuticals has closed a $25m Series A round from Johnson & Johnson Innovation – JJDC and others.
Read more news concerning TPG Biotech
A sampling of TPG Biotech portfolio companies:
View all of the investments in their portfolio
This firm also pursues other investment strategies:
Registration is fast, free and easy
Already a member?